Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Stuart A Arbuckle. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Stuart A Arbuckle har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:VRTX / Vertex Pharmaceuticals Incorporated | EVP, COO | 63 368 |
US:RYTM / Rhythm Pharmaceuticals, Inc. | Director | 7 000 |
US:IMGN / ImmunoGen, Inc. | Director | 0 |
US:CERU / Cerulean Pharma Inc. | Director | 13 104 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Stuart A Arbuckle. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp DARE / Daré Bioscience, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i DARE / Daré Bioscience, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i DARE / Daré Bioscience, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp RYTM / Rhythm Pharmaceuticals, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i DARE / Daré Bioscience, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i DARE / Daré Bioscience, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Stuart A Arbuckle som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-07-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −37 243 | 63 368 | −37,02 | 450,23 | −16 767 916 | 28 530 175 | |
2025-06-23 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 4 000 | 7 000 | 133,33 | ||||
2025-05-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 37 622 | 100 611 | 59,73 | ||||
2025-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −7 071 | 62 935 | −10,10 | 479,61 | −3 391 322 | 30 184 255 | |
2025-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −4 716 | 70 006 | −6,31 | 483,28 | −2 279 148 | 33 832 500 | |
2025-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −2 724 | 74 722 | −3,52 | 463,46 | −1 262 465 | 34 630 658 | |
2025-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 7 903 | 77 446 | 11,36 | ||||
2025-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −3 220 | 69 543 | −4,43 | 467,98 | −1 506 896 | 32 544 733 | |
2025-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 448 | 72 763 | 13,14 | ||||
2025-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 14 624 | 64 315 | 29,43 | ||||
2024-06-25 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Common Stock |
M - Exercise | 3 000 | 3 000 | |||||
2024-05-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −69 | 49 691 | −0,14 | 430,93 | −29 734 | 21 413 343 |
2024-02-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 034 | 49 691 | −9,20 | 425,70 | −2 142 974 | 21 153 459 |
2024-02-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −4 714 | 54 725 | −7,93 | 431,79 | −2 035 458 | 23 629 708 | |
2024-02-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 603 | 59 439 | −5,72 | 421,77 | −1 519 637 | 25 069 587 |
2024-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 804 | 63 042 | −7,08 | 420,79 | −2 021 475 | 26 527 443 |
2024-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −3 373 | 67 846 | −4,74 | 420,58 | −1 418 616 | 28 534 671 | |
2024-02-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −4 499 | 71 219 | −5,94 | 424,01 | −1 907 621 | 30 197 568 | |
2024-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 295 | 75 718 | −5,37 | 420,24 | −1 804 931 | 31 819 732 |
2024-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −3 177 | 80 013 | −3,82 | 422,74 | −1 343 045 | 33 824 696 | |
2024-02-12 |
|
4 | IMGN |
ImmunoGen, Inc.
Common Stock |
D - Sale to Issuer | −5 381 | 0 | −100,00 | ||||
2024-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 448 | 83 190 | 11,30 | ||||
2024-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 11 210 | 74 742 | 17,64 | ||||
2024-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 6 976 | 63 532 | 12,33 | ||||
2024-01-03 |
|
4 | IMGN |
ImmunoGen, Inc.
Common Stock |
A - Award | 442 | 5 381 | 8,95 | 29,65 | 13 105 | 159 547 | |
2023-12-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −8 603 | 56 556 | −13,20 | 399,00 | −3 432 597 | 22 565 844 |
2023-12-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 8 603 | 65 159 | 15,21 | 187,53 | 1 613 321 | 12 219 267 | |
2023-10-02 |
|
4 | IMGN |
ImmunoGen, Inc.
Common Stock |
A - Award | 827 | 4 939 | 20,11 | 15,87 | 13 124 | 78 382 | |
2023-07-05 |
|
4 | IMGN |
ImmunoGen, Inc.
Common Stock |
A - Award | 695 | 4 112 | 20,34 | 18,87 | 13 115 | 77 593 | |
2023-06-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −8 603 | 56 556 | −13,20 | 349,00 | −3 002 447 | 19 738 044 |
2023-06-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 8 603 | 65 159 | 15,21 | 187,53 | 1 613 321 | 12 219 267 | |
2023-06-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −82 | 56 556 | −0,14 | 329,82 | −27 045 | 18 653 300 |
2023-04-04 |
|
4 | IMGN |
ImmunoGen, Inc.
Common Stock |
A - Award | 3 417 | 3 417 | 3,84 | 13 121 | 13 121 | ||
2023-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −800 | 56 556 | −1,39 | 288,92 | −231 136 | 16 340 160 |
2023-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 57 356 | −0,69 | 287,59 | −115 036 | 16 495 012 |
2023-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 834 | 57 756 | −6,23 | 287,16 | −1 100 971 | 16 585 213 |
2023-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −4 714 | 61 590 | −7,11 | 289,12 | −1 362 912 | 17 806 901 | |
2023-02-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 66 304 | −0,30 | 296,31 | −59 262 | 19 646 538 |
2023-02-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −394 | 66 504 | −0,59 | 295,38 | −116 380 | 19 643 952 |
2023-02-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 378 | 66 898 | −2,02 | 294,29 | −405 532 | 19 687 412 |
2023-02-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −300 | 68 276 | −0,44 | 292,86 | −87 858 | 19 995 309 |
2023-02-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −129 | 68 576 | −0,19 | 291,84 | −37 647 | 20 013 220 |
2023-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −736 | 68 705 | −1,06 | 294,58 | −216 811 | 20 239 119 |
2023-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 100 | 69 441 | −1,56 | 293,74 | −323 114 | 20 397 599 |
2023-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −545 | 70 541 | −0,77 | 292,77 | −159 560 | 20 652 289 |
2023-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −21 | 71 086 | −0,03 | 291,01 | −6 111 | 20 686 737 |
2023-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −4 498 | 71 107 | −5,95 | 292,85 | −1 317 239 | 20 823 685 | |
2023-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 75 605 | −0,53 | 300,89 | −120 356 | 22 748 788 |
2023-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 734 | 76 005 | −2,23 | 300,09 | −520 356 | 22 808 340 |
2023-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 003 | 77 739 | −2,51 | 299,13 | −599 157 | 23 254 067 |
2023-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −560 | 79 742 | −0,70 | 298,14 | −166 958 | 23 774 280 |
2023-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −901 | 80 302 | −1,11 | 296,85 | −267 462 | 23 837 649 |
2023-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −800 | 81 203 | −0,98 | 295,84 | −236 672 | 24 023 096 |
2023-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −835 | 82 003 | −1,01 | 300,13 | −250 609 | 24 611 560 |
2023-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 779 | 82 838 | −2,10 | 299,26 | −532 384 | 24 790 100 |
2023-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 028 | 84 617 | −2,34 | 298,42 | −605 196 | 25 251 405 |
2023-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −245 | 86 645 | −0,28 | 296,44 | −72 628 | 25 685 044 |
2023-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −5 990 | 86 890 | −6,45 | 298,26 | −1 786 577 | 25 915 811 | |
2023-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −3 372 | 92 880 | −3,50 | 294,33 | −992 481 | 27 337 370 | |
2023-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 11 209 | 96 252 | 13,18 | ||||
2023-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 14 624 | 85 043 | 20,77 | ||||
2023-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 12 388 | 70 419 | 21,35 | ||||
2022-12-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 12 753 | 58 031 | 28,17 | ||||
2022-08-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −6 948 | 45 278 | −13,30 | 305,38 | −2 121 780 | 13 826 996 |
2022-08-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −6 990 | 52 226 | −11,80 | 304,67 | −2 129 643 | 15 911 695 |
2022-08-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 339 | 59 216 | −3,80 | 303,78 | −710 541 | 17 988 636 |
2022-08-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 61 555 | −0,65 | 302,55 | −121 020 | 18 623 465 |
2022-08-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 242 | 61 955 | −6,41 | 301,61 | −1 279 430 | 18 686 248 |
2022-08-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 254 | 66 197 | −1,86 | 300,30 | −376 576 | 19 878 959 |
2022-08-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 6 571 | 67 451 | 10,79 | 155,57 | 1 022 250 | 10 493 352 | |
2022-08-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −9 | 60 880 | −0,01 | 302,01 | −2 718 | 18 386 369 |
2022-08-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −171 | 60 889 | −0,28 | 300,32 | −51 355 | 18 286 184 |
2022-08-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 64 | 61 060 | 0,10 | 155,57 | 9 956 | 9 499 104 | |
2022-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −900 | 60 996 | −1,45 | 301,42 | −271 278 | 18 385 414 |
2022-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 790 | 61 896 | −7,18 | 300,53 | −1 439 539 | 18 601 605 |
2022-08-10 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 926 | 66 686 | 2,97 | 155,57 | 299 628 | 10 374 341 | |
2022-05-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −40 | 64 760 | −0,06 | 254,19 | −10 168 | 16 461 344 |
2022-05-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 | 64 800 | −0,02 | 252,66 | −2 527 | 16 372 368 |
2022-05-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 | 64 810 | −0,02 | 251,43 | −2 514 | 16 295 178 |
2022-05-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −32 | 64 820 | −0,05 | 250,78 | −8 025 | 16 255 560 |
2022-05-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −20 | 64 852 | −0,03 | 249,35 | −4 987 | 16 170 846 |
2022-05-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 | 64 872 | −0,02 | 247,95 | −2 480 | 16 085 012 |
2022-05-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −11 | 64 882 | −0,02 | 246,21 | −2 708 | 15 974 597 |
2022-05-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −306 | 64 760 | −0,47 | 263,98 | −80 778 | 17 095 345 |
2022-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −7 246 | 65 066 | −10,02 | 227,86 | −1 651 074 | 14 825 939 | |
2022-02-22 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −4 126 | 72 312 | −5,40 | 232,51 | −959 336 | 16 813 263 | |
2022-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −3 040 | 76 438 | −3,82 | 237,74 | −722 730 | 18 172 370 | |
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 14 623 | 79 478 | 22,55 | ||||
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 13 952 | 64 855 | 27,41 | ||||
2022-02-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 9 800 | 50 903 | 23,84 | ||||
2021-11-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 | 41 103 | 0,00 | 187,80 | −188 | 7 719 143 |
2021-11-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 | 41 104 | 0,00 | 186,99 | −374 | 7 686 037 |
2021-06-17 |
|
4 | IMGN |
ImmunoGen, Inc.
Stock Option (right to buy) |
A - Award | 44 000 | 44 000 | 6,77 | 297 880 | 297 880 | ||
2021-06-17 |
|
4 | IMGN |
ImmunoGen, Inc.
Deferred Share Unit |
A - Award | 15 000 | 48 000 | 45,45 | ||||
2021-06-11 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2021-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −16 | 41 103 | −0,04 | 217,15 | −3 474 | 8 925 516 |
2021-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −86 | 41 119 | −0,21 | 216,36 | −18 607 | 8 896 507 |
2021-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −7 | 41 205 | −0,02 | 215,33 | −1 507 | 8 872 673 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −254 | 41 103 | −0,61 | 216,57 | −55 009 | 8 901 677 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −300 | 41 357 | −0,72 | 215,62 | −64 686 | 8 917 396 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 41 657 | −0,95 | 214,32 | −85 728 | 8 927 928 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 400 | 42 057 | −3,22 | 213,55 | −298 970 | 8 981 272 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −900 | 43 457 | −2,03 | 212,52 | −191 268 | 9 235 482 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −380 | 44 357 | −0,85 | 211,39 | −80 328 | 9 376 626 |
2021-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −2 898 | 44 737 | −6,08 | 217,57 | −630 518 | 9 733 429 | |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 47 635 | −0,21 | 213,26 | −21 326 | 10 158 640 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 763 | 47 735 | −5,47 | 212,49 | −587 110 | 10 143 210 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 940 | 50 498 | −7,24 | 211,77 | −834 374 | 10 693 961 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 022 | 54 438 | −1,84 | 210,05 | −214 671 | 11 434 702 |
2021-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −6 240 | 55 460 | −10,11 | 211,75 | −1 321 320 | 11 743 655 | |
2021-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 61 700 | −0,32 | 212,10 | −42 420 | 13 086 570 |
2021-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −600 | 61 900 | −0,96 | 211,19 | −126 714 | 13 072 661 |
2021-02-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 356 | 62 500 | −6,52 | 210,39 | −916 459 | 13 149 375 |
2021-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −3 101 | 66 856 | −4,43 | 214,16 | −664 110 | 14 317 881 | |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 554 | 0 | −100,00 | ||||
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −89 | 69 957 | −0,13 | 216,83 | −19 298 | 15 168 776 |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −90 | 70 046 | −0,13 | 215,80 | −19 422 | 15 115 927 |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −242 | 70 136 | −0,34 | 214,98 | −52 025 | 15 077 837 |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −497 | 70 378 | −0,70 | 213,90 | −106 308 | 15 053 854 |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −488 | 70 875 | −0,68 | 212,77 | −103 832 | 15 080 074 |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −148 | 71 363 | −0,21 | 211,22 | −31 261 | 15 073 293 |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 554 | 71 511 | 2,22 | 86,52 | 134 452 | 6 187 132 | |
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 13 952 | 69 957 | 24,91 | ||||
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 12 388 | 56 005 | 28,40 | ||||
2021-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 438 | 43 617 | 23,99 | ||||
2020-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 | 35 179 | −0,01 | 224,11 | −1 121 | 7 883 966 |
2020-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 | 35 184 | −0,01 | 222,47 | −445 | 7 827 384 |
2020-11-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 553 | 1 554 | −49,98 | ||||
2020-11-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −334 | 35 179 | −0,94 | 214,13 | −71 519 | 7 532 879 |
2020-11-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −245 | 35 513 | −0,69 | 212,38 | −52 033 | 7 542 251 |
2020-11-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −487 | 35 758 | −1,34 | 211,54 | −103 020 | 7 564 247 |
2020-11-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −487 | 36 245 | −1,33 | 210,56 | −102 543 | 7 631 747 |
2020-11-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 553 | 36 732 | 4,41 | 86,52 | 134 366 | 3 178 053 | |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 553 | 3 107 | −33,33 | ||||
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −280 | 35 179 | −0,79 | 279,58 | −78 282 | 9 835 345 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −689 | 35 459 | −1,91 | 278,72 | −192 038 | 9 883 132 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −413 | 36 148 | −1,13 | 277,85 | −114 752 | 10 043 722 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −171 | 36 561 | −0,47 | 276,40 | −47 264 | 10 105 460 |
2020-08-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 553 | 36 732 | 4,41 | 86,52 | 134 366 | 3 178 053 | |
2020-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to buy) |
M - Exercise | −1 222 | 8 561 | −12,49 | ||||
2020-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to buy) |
M - Exercise | −1 564 | 17 206 | −8,33 | ||||
2020-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 786 | 35 179 | −7,34 | 300,00 | −835 800 | 10 553 700 |
2020-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 222 | 37 965 | 3,33 | 155,57 | 190 107 | 5 906 215 | |
2020-07-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 564 | 36 743 | 4,45 | 187,53 | 293 297 | 6 890 415 | |
2020-06-18 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Stock Option (right to buy) |
A - Award | 18 500 | 18 500 | |||||
2020-06-18 |
|
4 | IMGN |
ImmunoGen, Inc.
Stock Option (right to buy) |
A - Award | 50 000 | 50 000 | 4,56 | 228 000 | 228 000 | ||
2020-06-18 |
|
4 | IMGN |
ImmunoGen, Inc.
Deferred Share Unit |
A - Award | 17 000 | 33 000 | 106,25 | ||||
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −9 | 35 179 | −0,03 | 288,35 | −2 595 | 10 143 865 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −24 | 35 188 | −0,07 | 287,62 | −6 903 | 10 120 773 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −21 | 35 212 | −0,06 | 286,41 | −6 015 | 10 085 069 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 | 35 233 | −0,03 | 285,00 | −2 850 | 10 041 405 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 | 35 243 | −0,03 | 283,58 | −2 836 | 9 994 210 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −12 | 35 253 | −0,03 | 280,71 | −3 369 | 9 895 870 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −17 | 35 265 | −0,05 | 279,93 | −4 759 | 9 871 731 |
2020-05-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 | 35 282 | −0,03 | 276,35 | −2 764 | 9 750 181 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 553 | 4 660 | −25,00 | ||||
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −113 | 35 179 | −0,32 | 264,89 | −29 933 | 9 318 565 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −240 | 35 292 | −0,68 | 262,54 | −63 010 | 9 265 562 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −240 | 35 532 | −0,67 | 261,34 | −62 722 | 9 285 933 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −320 | 35 772 | −0,89 | 260,32 | −83 302 | 9 312 167 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −640 | 36 092 | −1,74 | 259,36 | −165 990 | 9 360 821 |
2020-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 553 | 36 732 | 4,41 | 86,52 | 134 366 | 3 178 053 | |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −632 | 35 179 | −1,76 | 238,33 | −150 625 | 8 384 211 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −20 | 35 811 | −0,06 | 236,88 | −4 738 | 8 482 910 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −420 | 35 831 | −1,16 | 236,36 | −99 271 | 8 469 015 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −540 | 36 251 | −1,47 | 235,14 | −126 976 | 8 524 060 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −420 | 36 791 | −1,13 | 234,08 | −98 314 | 8 612 037 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −360 | 37 211 | −0,96 | 232,35 | −83 646 | 8 645 976 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −432 | 37 571 | −1,14 | 230,85 | −99 727 | 8 673 265 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −810 | 38 003 | −2,09 | 229,78 | −186 122 | 8 732 329 |
2020-02-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −2 898 | 38 813 | −6,95 | 239,23 | −693 289 | 9 285 234 | |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −377 | 41 711 | −0,90 | 245,76 | −92 652 | 10 250 895 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −580 | 42 088 | −1,36 | 245,04 | −142 123 | 10 313 244 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 42 668 | −0,93 | 243,76 | −97 504 | 10 400 752 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 011 | 43 068 | −2,29 | 242,91 | −245 582 | 10 461 648 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −760 | 44 079 | −1,69 | 242,08 | −183 981 | 10 670 644 |
2020-02-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −2 496 | 44 839 | −5,27 | 241,50 | −602 784 | 10 828 618 | |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −486 | 47 335 | −1,02 | 248,62 | −120 829 | 11 768 428 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 863 | 47 821 | −3,75 | 247,91 | −461 856 | 11 855 304 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 770 | 49 684 | −3,44 | 246,76 | −436 765 | 12 260 024 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 377 | 51 454 | −6,16 | 245,93 | −830 506 | 12 654 082 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 860 | 54 831 | −4,96 | 244,99 | −700 671 | 13 433 047 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −930 | 57 691 | −1,59 | 243,76 | −226 697 | 14 062 758 |
2020-02-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
F - Taxes | −8 942 | 58 621 | −13,24 | 240,95 | −2 154 575 | 14 124 730 | |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 223 | 9 783 | −11,11 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 564 | 18 770 | −7,69 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −171 | 67 563 | −0,25 | 242,47 | −41 462 | 16 382 001 |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −150 | 67 734 | −0,22 | 241,08 | −36 162 | 16 329 313 |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −230 | 67 884 | −0,34 | 240,53 | −55 322 | 16 328 139 |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −725 | 68 114 | −1,05 | 239,47 | −173 616 | 16 311 260 |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 511 | 68 839 | −2,15 | 238,71 | −360 691 | 16 432 558 |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 223 | 70 350 | 1,77 | 155,57 | 190 262 | 10 944 350 | |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 564 | 69 127 | 2,31 | 187,53 | 293 297 | 12 963 386 | |
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 12 387 | 67 563 | 22,45 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 9 800 | 55 176 | 21,60 | ||||
2020-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 12 136 | 45 376 | 36,51 | ||||
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 554 | 6 213 | −20,01 | ||||
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 156 | 0 | −100,00 | ||||
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −540 | 33 240 | −1,60 | 232,71 | −125 663 | 7 735 280 |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −900 | 33 780 | −2,60 | 231,87 | −208 683 | 7 832 569 |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 300 | 34 680 | −3,61 | 231,16 | −300 508 | 8 016 629 |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −530 | 35 980 | −1,45 | 229,99 | −121 895 | 8 275 040 |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −440 | 36 510 | −1,19 | 228,90 | −100 716 | 8 357 139 |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | −1 554 | 36 950 | −4,04 | 86,52 | −134 452 | 3 196 914 | |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | −2 156 | 35 396 | −5,74 | 91,05 | −196 304 | 3 222 806 | |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −4 692 | 20 334 | −18,75 | ||||
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 692 | 33 240 | −12,37 | 238,65 | −1 119 746 | 7 932 726 |
2020-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 692 | 37 932 | 14,12 | 187,53 | 879 891 | 7 113 388 | |
2019-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −19 | 33 240 | −0,06 | 205,95 | −3 913 | 6 845 778 |
2019-11-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −8 560 | 11 006 | −43,75 | ||||
2019-11-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −8 560 | 33 240 | −20,48 | 205,57 | −1 759 679 | 6 833 147 |
2019-11-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 8 560 | 41 800 | 25,75 | 155,57 | 1 331 679 | 6 502 826 | |
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 553 | 7 767 | −16,66 | ||||
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 155 | 2 156 | −49,99 | ||||
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 553 | 33 240 | −4,46 | 201,62 | −313 116 | 6 701 849 |
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 553 | 34 793 | 4,67 | 86,52 | 134 366 | 3 010 290 | |
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | −2 155 | 33 240 | −6,09 | 201,62 | −434 491 | 6 701 849 | |
2019-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 155 | 35 395 | 6,48 | 91,05 | 196 213 | 3 222 715 | |
2019-08-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 2 125 | 0 | −100,00 | ||||
2019-08-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 125 | 33 240 | −6,01 | 181,89 | −386 516 | 6 046 024 |
2019-08-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 35 365 | 6,39 | 131,89 | 280 266 | 4 664 290 | |
2019-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 1 553 | 9 320 | 19,99 | ||||
2019-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 553 | 32 240 | −4,60 | 176,44 | −274 011 | 5 688 426 |
2019-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 553 | 33 793 | 4,82 | 86,52 | 134 366 | 2 923 770 | |
2019-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 2 155 | 4 311 | 99,95 | ||||
2019-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 155 | 32 240 | −6,27 | 177,78 | −383 116 | 5 731 627 |
2019-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 155 | 34 395 | 6,68 | 91,05 | 196 213 | 3 131 665 | |
2019-08-01 |
|
4 | RYTM |
RHYTHM PHARMACEUTICALS, INC.
Stock Option (right to buy) |
A - Award | 30 000 | 30 000 | |||||
2019-06-24 |
|
4 | IMGN |
IMMUNOGEN INC
Stock Option (right to buy) |
A - Award | 18 000 | 18 000 | 2,10 | 37 800 | 37 800 | ||
2019-06-24 |
|
4 | IMGN |
IMMUNOGEN INC
Deferred Share Unit |
A - Award | 4 000 | 16 000 | 33,33 | ||||
2019-06-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 125 | 2 125 | −50,00 | ||||
2019-06-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 125 | 33 240 | −6,01 | 181,89 | −386 516 | 6 046 024 |
2019-06-20 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 35 365 | 6,39 | 131,89 | 280 266 | 4 664 290 | |
2019-05-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −133 | 33 240 | −0,40 | 165,41 | −22 000 | 5 498 228 |
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 1 553 | 10 873 | 16,66 | ||||
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −593 | 33 240 | −1,75 | 173,60 | −102 945 | 5 770 464 |
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 33 833 | −1,17 | 172,73 | −69 092 | 5 843 974 |
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −320 | 34 233 | −0,93 | 171,31 | −54 819 | 5 864 455 |
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
CommonStock |
S - Sale | X | −240 | 34 553 | −0,69 | 170,28 | −40 867 | 5 883 685 |
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 553 | 34 793 | 4,67 | 86,52 | 134 366 | 3 010 290 | |
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 2 155 | 6 466 | 49,99 | ||||
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 33 240 | −0,30 | 171,70 | −17 170 | 5 707 308 |
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 33 340 | −1,19 | 170,72 | −68 288 | 5 691 805 |
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −457 | 33 740 | −1,34 | 169,31 | −77 375 | 5 712 519 |
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 198 | 34 197 | −3,38 | 168,56 | −201 935 | 5 764 246 |
2019-05-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 155 | 35 395 | 6,48 | 91,05 | 196 213 | 3 222 715 | |
2019-04-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −320 | 33 240 | −0,95 | 183,61 | −58 755 | 6 103 196 |
2019-04-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 712 | 33 560 | −7,48 | 182,29 | −494 370 | 6 117 652 |
2019-04-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 592 | 36 272 | −6,67 | 180,95 | −469 022 | 6 563 418 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −7 501 | 38 864 | −16,18 | 181,03 | −1 357 906 | 7 035 550 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −14 915 | 46 365 | −24,34 | 180,34 | −2 689 771 | 8 361 464 |
2019-02-13 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 657 | 61 280 | −14,81 | 179,44 | −1 912 292 | 10 996 083 |
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 25 026 | 25 026 | |||||
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 9 799 | 71 937 | 15,77 | ||||
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 438 | 62 138 | 15,71 | ||||
2019-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 17 298 | 53 700 | 47,52 | ||||
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 1 554 | 12 426 | 14,29 | ||||
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 2 155 | 8 621 | 33,33 | ||||
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 4 250 | 0 | −100,00 | ||||
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −300 | 36 402 | −0,82 | 188,07 | −56 421 | 6 846 124 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 044 | 36 702 | −9,92 | 186,84 | −755 581 | 6 857 402 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −12 565 | 40 746 | −23,57 | 186,10 | −2 338 346 | 7 582 831 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 400 | 53 311 | −2,56 | 184,81 | −258 734 | 9 852 406 |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 554 | 54 711 | 2,92 | 86,52 | 134 452 | 4 733 596 | |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 155 | 53 157 | 4,23 | 91,05 | 196 213 | 4 839 945 | |
2019-02-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 51 002 | 9,09 | 109,41 | 464 992 | 5 580 129 | |
2019-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 125 | 4 250 | −33,33 | ||||
2019-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 125 | 46 752 | −4,35 | 193,48 | −411 145 | 9 045 577 |
2019-01-24 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 48 877 | 4,55 | 131,89 | 280 266 | 6 446 388 | |
2018-11-19 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −29 | 46 752 | −0,06 | 163,75 | −4 749 | 7 655 640 |
2018-11-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 2 125 | 6 375 | 50,00 | ||||
2018-11-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 125 | 46 752 | −4,35 | 179,00 | −380 375 | 8 368 608 |
2018-11-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 48 877 | 4,55 | 131,89 | 280 266 | 6 446 388 | |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 1 553 | 13 980 | 12,50 | ||||
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 4 250 | 4 250 | |||||
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 553 | 46 752 | −3,21 | 172,08 | −267 240 | 8 045 084 |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 553 | 48 305 | 3,32 | 86,52 | 134 366 | 4 179 349 | |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 250 | 46 752 | −8,33 | 172,08 | −731 340 | 8 045 084 |
2018-11-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 51 002 | 9,09 | 109,14 | 463 845 | 5 566 358 | |
2018-11-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | 2 155 | 10 776 | 25,00 | ||||
2018-11-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 155 | 46 752 | −4,41 | 175,36 | −377 901 | 8 198 431 |
2018-11-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 155 | 48 907 | 4,61 | 91,05 | 196 213 | 4 452 982 | |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 553 | 15 533 | −9,09 | ||||
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −4 250 | 8 500 | −33,33 | ||||
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 803 | 46 752 | −11,04 | 174,20 | −1 010 883 | 8 144 198 |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 553 | 52 555 | 3,04 | 86,52 | 134 366 | 4 547 059 | |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 51 002 | 9,09 | 109,14 | 463 845 | 5 566 358 | |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 155 | 12 931 | −14,28 | ||||
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 125 | 8 500 | −20,00 | ||||
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 155 | 46 752 | −4,41 | 174,59 | −376 241 | 8 162 432 |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 155 | 48 907 | 4,61 | 91,05 | 196 213 | 4 452 982 | |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 125 | 46 752 | −4,35 | 179,00 | −380 375 | 8 368 608 |
2018-08-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 48 877 | 4,55 | 131,89 | 280 266 | 6 446 388 | |
2018-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 125 | 0 | −100,00 | ||||
2018-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 125 | 46 752 | −4,35 | 179,85 | −382 181 | 8 408 347 |
2018-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 48 877 | 4,55 | 96,87 | 205 849 | 4 734 715 | |
2018-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −6 375 | 10 625 | −37,50 | ||||
2018-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −6 375 | 46 752 | −12,00 | 179,00 | −1 141 125 | 8 368 608 |
2018-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 6 375 | 53 127 | 13,64 | 131,89 | 840 799 | 7 006 920 | |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 553 | 17 086 | −8,33 | ||||
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 155 | 15 086 | −12,50 | ||||
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 708 | 46 752 | −7,35 | 169,00 | −626 652 | 7 901 088 |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 553 | 50 460 | 3,18 | 86,52 | 134 366 | 4 365 799 | |
2018-07-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 155 | 48 907 | 4,61 | 91,05 | 196 213 | 4 452 982 | |
2018-06-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −4 250 | 12 750 | −25,00 | ||||
2018-06-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 250 | 46 752 | −8,33 | 159,00 | −675 750 | 7 433 568 |
2018-06-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 51 002 | 9,09 | 109,14 | 463 845 | 5 566 358 | |
2018-06-22 |
|
4 | IMGN |
IMMUNOGEN INC
Stock option (right to buy) |
A - Award | 15 800 | 15 800 | 11,21 | 177 118 | 177 118 | ||
2018-06-22 |
|
4 | IMGN |
IMMUNOGEN INC
Deferred Share Unit |
A - Award | 1 500 | 12 000 | 14,29 | ||||
2018-06-22 |
|
4 | IMGN |
IMMUNOGEN INC
Stock option (right to buy) |
A - Award | 18 000 | 18 000 | 11,21 | 201 780 | 201 780 | ||
2018-06-22 |
|
4 | IMGN |
IMMUNOGEN INC
Deferred Share Unit |
A - Award | 4 000 | 10 500 | 61,54 | ||||
2018-05-16 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −138 | 46 752 | −0,29 | 155,78 | −21 498 | 7 283 027 |
2018-04-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 125 | 2 125 | −50,00 | ||||
2018-04-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 125 | 46 752 | −4,35 | 163,01 | −346 396 | 7 621 044 |
2018-04-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 48 877 | 4,55 | 96,87 | 205 849 | 4 734 715 | |
2018-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −1 554 | 18 639 | −7,70 | ||||
2018-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −6 459 | 46 752 | −12,14 | 169,00 | −1 091 571 | 7 901 088 |
2018-02-28 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 1 554 | 53 211 | 3,01 | 86,52 | 134 452 | 4 603 816 | |
2018-02-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 022 | 51 657 | −3,77 | 152,26 | −307 870 | 7 865 295 |
2018-02-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 022 | 53 679 | −3,63 | 151,40 | −306 131 | 8 127 001 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 270 | 55 701 | −2,23 | 153,80 | −195 326 | 8 566 814 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 879 | 56 971 | −6,37 | 153,07 | −593 759 | 8 720 551 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −800 | 60 850 | −1,30 | 152,27 | −121 816 | 9 265 630 |
2018-02-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −875 | 61 650 | −1,40 | 150,78 | −131 932 | 9 295 587 |
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 19 566 | 19 566 | |||||
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 8 437 | 62 525 | 15,60 | ||||
2018-02-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 12 136 | 54 088 | 28,93 | ||||
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −4 250 | 17 000 | −20,00 | ||||
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −4 250 | 17 000 | −20,00 | ||||
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −8 500 | 41 952 | −16,85 | 163,08 | −1 386 180 | 6 841 532 |
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 50 452 | 9,20 | 109,14 | 463 845 | 5 506 331 | |
2018-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 46 202 | 10,13 | 77,31 | 328 568 | 3 571 877 | |
2018-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 156 | 17 241 | −11,12 | ||||
2018-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 156 | 41 952 | −4,89 | 169,42 | −365 270 | 7 107 508 |
2018-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 156 | 44 108 | 5,14 | 91,05 | 196 304 | 4 016 033 | |
2018-01-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −4 659 | 20 193 | −18,75 | ||||
2018-01-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −4 310 | 19 397 | −18,18 | ||||
2018-01-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −8 969 | 41 952 | −17,61 | 169,00 | −1 515 761 | 7 089 888 |
2018-01-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 659 | 50 921 | 10,07 | 86,52 | 403 097 | 4 405 685 | |
2018-01-26 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 310 | 46 262 | 10,27 | 91,05 | 392 426 | 4 212 155 | |
2018-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 125 | 4 250 | −33,33 | ||||
2018-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 125 | 41 952 | −4,82 | 158,28 | −336 345 | 6 640 163 |
2018-01-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 44 077 | 5,07 | 96,87 | 205 849 | 4 269 739 | |
2018-01-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −4 250 | 21 250 | −16,67 | ||||
2018-01-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 250 | 41 952 | −9,20 | 159,00 | −675 750 | 6 670 368 |
2018-01-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 46 202 | 10,13 | 109,14 | 463 845 | 5 042 486 | |
2017-12-06 |
|
4/A | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −48 | 41 952 | −0,11 | 147,29 | −7 070 | 6 179 110 |
2017-11-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −221 | 41 952 | −0,52 | 147,29 | −32 551 | 6 179 110 |
2017-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −4 250 | 4 250 | −50,00 | ||||
2017-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 250 | 41 952 | −9,20 | 148,17 | −629 722 | 6 216 028 |
2017-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 46 202 | 10,13 | 77,31 | 328 568 | 3 571 877 | |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −500 | 41 952 | −1,18 | 149,34 | −74 670 | 6 265 112 |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 000 | 42 452 | −2,30 | 148,54 | −148 540 | 6 305 820 |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 000 | 43 452 | −10,32 | 147,87 | −739 350 | 6 425 247 |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −7 783 | 48 452 | −13,84 | 146,61 | −1 141 066 | 7 103 548 |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −17 501 | 56 235 | −23,73 | 145,34 | −2 543 595 | 8 173 195 |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −25 999 | 73 736 | −26,07 | 144,54 | −3 757 895 | 10 657 801 |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 600 | 99 735 | −5,32 | 143,54 | −803 824 | 14 315 962 |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −11 617 | 105 335 | −9,93 | 142,18 | −1 651 705 | 14 976 530 |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 125 | 6 375 | −25,00 | ||||
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 125 | 116 952 | −1,78 | 149,00 | −316 625 | 17 425 848 |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 119 077 | 1,82 | 96,87 | 205 849 | 11 534 989 | |
2017-10-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 165 | 116 952 | −3,44 | 141,41 | −588 973 | 16 538 182 |
2017-08-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −4 250 | 8 500 | −33,33 | ||||
2017-08-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 250 | 121 117 | −3,39 | 152,88 | −649 740 | 18 516 367 |
2017-08-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 125 367 | 3,51 | 77,31 | 328 568 | 9 692 123 | |
2017-08-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −4 250 | 25 500 | −14,29 | ||||
2017-08-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 250 | 121 117 | −3,39 | 155,72 | −661 810 | 18 860 339 |
2017-08-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 125 367 | 3,51 | 109,14 | 463 845 | 13 682 554 | |
2017-08-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 125 | 0 | −100,00 | ||||
2017-08-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 125 | 121 117 | −1,72 | 152,99 | −325 104 | 18 529 690 |
2017-08-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 123 242 | 1,75 | 83,36 | 177 140 | 10 273 453 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −2 125 | 17 000 | −11,11 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 121 117 | −0,16 | 161,72 | −32 344 | 19 587 041 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −10 150 | 121 317 | −7,72 | 161,68 | −1 641 052 | 19 614 533 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 125 | 131 467 | −1,59 | 159,00 | −337 875 | 20 903 253 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 2 125 | 133 592 | 1,62 | 131,89 | 280 266 | 17 619 449 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −10 775 | 23 707 | −31,25 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −14 875 | 19 125 | −43,75 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −38 250 | 38 250 | −50,00 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −25 500 | 8 500 | −75,00 | ||||
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −29 000 | 131 467 | −18,07 | 162,67 | −4 717 430 | 21 385 737 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −60 400 | 160 467 | −27,35 | 161,00 | −9 724 400 | 25 835 187 |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 10 775 | 220 867 | 5,13 | 91,05 | 981 064 | 20 109 940 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 14 875 | 210 092 | 7,62 | 131,89 | 1 961 864 | 27 709 034 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 38 250 | 195 217 | 24,37 | 109,14 | 4 174 605 | 21 305 983 | |
2017-07-21 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 25 500 | 156 967 | 19,40 | 96,87 | 2 470 185 | 15 205 393 | |
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −31 875 | 2 125 | −93,75 | ||||
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −25 500 | 12 750 | −66,67 | ||||
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −57 375 | 131 467 | −30,38 | 129,02 | −7 402 522 | 16 961 872 |
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 31 875 | 188 842 | 20,31 | 83,36 | 2 657 100 | 15 741 869 | |
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 25 500 | 156 967 | 19,40 | 77,31 | 1 971 405 | 12 135 119 | |
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −13 594 | 0 | −100,00 | ||||
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −13 594 | 131 467 | −9,37 | 124,00 | −1 685 656 | 16 301 908 |
2017-06-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 13 594 | 145 061 | 10,34 | 53,74 | 730 542 | 7 795 578 | |
2017-05-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
M - Exercise | −28 320 | 0 | −100,00 | ||||
2017-05-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −28 320 | 131 247 | −17,75 | 119,50 | −3 384 240 | 15 684 016 |
2017-05-02 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 28 320 | 159 567 | 21,58 | 45,11 | 1 277 515 | 7 198 067 | |
2017-02-15 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 792 | 127 455 | −2,89 | 88,39 | −335 175 | 11 265 747 |
2017-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 24 852 | 24 852 | |||||
2017-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 12 136 | 131 247 | 10,19 | ||||
2017-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 5 753 | 119 111 | 5,08 | 0,01 | 58 | 1 191 | |
2017-01-05 |
|
4 | CERU |
Cerulean Pharma Inc.
Common Stock |
A - Award | 7 467 | 13 104 | 132,46 | 0,77 | 5 750 | 10 090 | |
2016-11-14 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 208 | 113 358 | −1,05 | 90,00 | −108 720 | 10 202 220 |
2016-10-20 |
|
4 | CERU |
Cerulean Pharma Inc.
Common Stock |
A - Award | 5 637 | 5 637 | 1,02 | 5 750 | 5 750 | ||
2016-10-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 208 | 114 566 | −1,04 | 86,46 | −104 444 | 9 905 376 |
2016-06-24 |
|
4 | CERU |
Cerulean Pharma Inc.
Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2016-05-27 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
G - Gift | −150 | 115 774 | −0,13 | ||||
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −645 | 115 721 | −0,55 | 92,80 | −59 856 | 10 738 909 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −700 | 116 366 | −0,60 | 91,89 | −64 323 | 10 692 872 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 100 | 117 066 | −1,76 | 90,98 | −191 058 | 10 650 665 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 597 | 119 166 | −2,13 | 89,92 | −233 522 | 10 715 407 |
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (Right to Buy) |
A - Award | 34 482 | 34 482 | |||||
2016-02-04 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 17 299 | 121 763 | 16,56 | 0,01 | 173 | 1 218 | |
2015-12-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −4 531 | 13 594 | −25,00 | ||||
2015-12-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 104 464 | −0,10 | 125,17 | −12 517 | 13 075 759 |
2015-12-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 252 | 104 564 | −2,11 | 124,36 | −280 059 | 13 003 579 |
2015-12-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 179 | 106 816 | −2,00 | 123,53 | −269 172 | 13 194 980 |
2015-12-08 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 531 | 108 995 | 4,34 | 53,74 | 243 496 | 5 857 391 | |
2015-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −3 650 | 38 250 | −8,71 | ||||
2015-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 650 | 104 464 | −3,38 | 124,00 | −452 600 | 12 953 536 |
2015-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 108 114 | −0,09 | 123,00 | −12 300 | 13 298 022 |
2015-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −143 | 108 214 | −0,13 | 122,47 | −17 513 | 13 252 969 |
2015-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −184 | 108 357 | −0,17 | 121,95 | −22 439 | 13 214 136 |
2015-11-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 3 650 | 108 541 | 3,48 | 77,31 | 282 182 | 8 391 305 | |
2015-11-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −600 | 41 900 | −1,41 | ||||
2015-11-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −5 664 | 28 320 | −16,67 | ||||
2015-11-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −200 | 104 748 | −0,19 | 125,17 | −25 034 | 13 111 307 |
2015-11-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 220 | 104 948 | −1,15 | 124,59 | −152 000 | 13 075 471 |
2015-11-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 400 | 106 168 | −2,21 | 123,04 | −295 296 | 13 062 911 |
2015-11-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 444 | 108 568 | −2,20 | 122,46 | −299 292 | 13 295 237 |
2015-11-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 600 | 111 012 | 0,54 | 77,31 | 46 386 | 8 582 338 | |
2015-11-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 5 664 | 110 412 | 5,41 | 45,11 | 255 503 | 4 980 685 | |
2015-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 500 | 104 748 | −4,12 | 126,31 | −568 395 | 13 230 720 |
2015-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 950 | 109 248 | −3,49 | 125,30 | −494 935 | 13 688 774 |
2015-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 000 | 113 198 | −0,88 | 124,44 | −124 440 | 14 086 359 |
2015-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −900 | 114 198 | −0,78 | 123,36 | −111 024 | 14 087 465 |
2015-10-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −600 | 115 098 | −0,52 | 106,07 | −63 642 | 12 208 445 |
2015-10-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 058 | 115 698 | −4,19 | 105,41 | −533 164 | 12 195 726 |
2015-10-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 159 | 120 756 | −4,10 | 104,45 | −538 858 | 12 612 964 |
2015-10-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −900 | 125 915 | −0,71 | 103,28 | −92 952 | 13 004 501 |
2015-10-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −700 | 126 815 | −0,55 | 102,30 | −71 610 | 12 973 174 |
2015-09-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −9 063 | 18 125 | −33,33 | ||||
2015-09-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 463 | 127 515 | −2,64 | 126,44 | −437 862 | 16 122 997 |
2015-09-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 200 | 130 978 | −3,82 | 125,42 | −652 184 | 16 427 261 |
2015-09-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 136 178 | −0,29 | 124,43 | −49 772 | 16 944 629 |
2015-09-09 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 9 063 | 136 578 | 7,11 | 53,74 | 487 046 | 7 339 702 | |
2015-08-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −8 500 | 42 500 | −16,67 | ||||
2015-08-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −11 328 | 33 984 | −25,00 | ||||
2015-08-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 300 | 127 515 | −1,77 | 142,18 | −327 014 | 18 130 083 |
2015-08-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −13 328 | 129 815 | −9,31 | 141,36 | −1 884 046 | 18 350 648 |
2015-08-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 200 | 143 143 | −2,85 | 140,51 | −590 142 | 20 113 023 |
2015-08-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 8 500 | 147 343 | 6,12 | 77,31 | 657 135 | 11 391 087 | |
2015-08-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 11 328 | 138 843 | 8,88 | 45,11 | 511 006 | 6 263 208 | |
2015-07-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 34 000 | 34 000 | |||||
2015-06-30 |
|
4 | CERU |
Cerulean Pharma Inc.
Stock Option (Right to Buy) |
A - Award | 22 000 | 22 000 | |||||
2015-06-30 | 3 | CERU |
Cerulean Pharma Inc.
No securities are beneficially owned. |
0 | ||||||||
2015-05-18 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −148 | 127 515 | −0,12 | 123,85 | −18 330 | 15 792 733 |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −17 000 | 51 000 | −25,00 | ||||
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −15 563 | 45 312 | −25,57 | ||||
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −18 312 | 27 188 | −40,25 | ||||
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −700 | 127 515 | −0,55 | 134,05 | −93 835 | 17 093 386 |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 400 | 128 215 | −2,58 | 133,34 | −453 356 | 17 096 188 |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −6 316 | 131 615 | −4,58 | 132,44 | −836 491 | 17 431 091 |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 230 | 137 931 | −2,98 | 131,27 | −555 272 | 18 106 202 |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −11 321 | 142 161 | −7,38 | 130,33 | −1 475 466 | 18 527 843 |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 100 | 153 482 | −0,71 | 129,30 | −142 230 | 19 845 223 |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −12 933 | 154 582 | −7,72 | 128,17 | −1 657 623 | 19 812 775 |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −21 480 | 167 515 | −11,37 | 127,49 | −2 738 485 | 21 356 487 |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 17 000 | 188 995 | 9,88 | 77,31 | 1 314 270 | 14 611 203 | |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 15 563 | 171 995 | 9,95 | 45,11 | 702 047 | 7 758 694 | |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 18 312 | 156 432 | 13,26 | 53,74 | 984 087 | 8 406 656 | |
2015-04-29 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
G - Gift | −150 | 138 120 | −0,11 | ||||
2015-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
A - Award | 68 000 | 68 000 | |||||
2015-02-05 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 20 700 | 138 270 | 17,61 | 0,01 | 207 | 1 383 | |
2014-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −4 250 | 60 875 | −6,53 | ||||
2014-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −300 | 117 264 | −0,26 | 113,98 | −34 194 | 13 365 751 |
2014-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 374 | 117 564 | −1,16 | 112,98 | −155 235 | 13 282 381 |
2014-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −2 576 | 118 938 | −2,12 | 112,07 | −288 692 | 13 329 382 |
2014-11-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 4 250 | 121 514 | 3,62 | 45,11 | 191 718 | 5 481 497 | |
2014-11-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 75 000 | 117 264 | 177,46 | 0,01 | 750 | 1 173 | |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −100 | 42 264 | −0,24 | 111,52 | −11 152 | 4 713 281 |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −400 | 42 364 | −0,94 | 110,37 | −44 148 | 4 675 715 |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −900 | 42 764 | −2,06 | 109,19 | −98 271 | 4 669 401 |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −4 037 | 43 664 | −8,46 | 108,08 | −436 319 | 4 719 205 |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −5 373 | 47 701 | −10,12 | 107,32 | −576 630 | 5 119 271 |
2014-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −1 607 | 53 074 | −2,94 | 106,32 | −170 856 | 5 642 828 |
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −25 500 | 65 125 | −28,14 | ||||
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option (right to buy) |
M - Exercise | −27 000 | 45 500 | −37,24 | ||||
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −55 521 | 54 681 | −50,38 | 100,00 | −5 552 100 | 5 468 100 |
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 25 500 | 110 202 | 30,11 | 45,11 | 1 150 305 | 4 971 212 | |
2014-09-23 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
M - Exercise | 27 000 | 84 702 | 46,79 | 53,74 | 1 450 980 | 4 551 885 | |
2014-07-17 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 34 000 | 34 000 | |||||
2014-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
A - Award | 68 000 | 68 000 | |||||
2014-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 20 700 | 57 418 | 56,38 | 0,01 | 207 | 574 | |
2013-12-12 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 021 | 36 718 | −7,60 | 65,47 | −197 785 | 2 403 927 |
2013-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −8 982 | 39 334 | −18,59 | 76,49 | −687 033 | 3 008 658 |
2013-10-03 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −3 435 | 48 316 | −6,64 | 75,73 | −260 133 | 3 658 971 |
2013-08-01 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Stock Option |
A - Award | 34 000 | 34 000 | |||||
2013-07-31 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
S - Sale | X | −347 | 51 751 | −0,67 | 79,87 | −27 715 | 4 133 352 |
2013-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
A - Award | 90 625 | 90 625 | |||||
2013-02-07 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 12 084 | 51 751 | 30,46 | 0,01 | 121 | 518 | |
2012-09-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Employee Stock Option (right to buy) |
A - Award | 72 500 | 72 500 | |||||
2012-09-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 30 000 | 39 667 | 310,33 | 0,01 | 300 | 397 | |
2012-09-06 |
|
4 | VRTX |
VERTEX PHARMACEUTICALS INC / MA
Common Stock |
A - Award | 9 667 | 9 667 | 0,01 | 97 | 97 |